logo
logo

Enbiotix, Inc. Closes $11M Pre-Merger Financing

Dec 29, 2021over 3 years ago

Amount Raised

$11 Million

Boston

Description

EnBiotix, Inc., a rare disease company currently focused on chronic respiratory disorders, today announced the closing of an $11M pre-merger, convertible note round of financing (“the Financing”) comprised of Vectura Group plc, the Cystic Fibrosis Foundation and Sanford Biosciences LLC.

Company Information

Company

En Biotix

Location

Boston, Massachusetts, United States

FundzWatch™ Score

66
Medium Activity

Buyer Intent Analysis

Get personalized insights on buying likelihood

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech